Jun 15, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Spherix Phase 2 Trial With D-tagatose Determines Minimum Dose For HbA1c And Triglycer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2428020" data-attributes="member: 124445"><p>Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested (2.5, 5.0, and 7.5 g TID), with the 2.5 and 5... <a href="http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/wt80nDgy1rc" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/wt80nDgy1rc/3NT7" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2428020, member: 124445"] Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested (2.5, 5.0, and 7.5 g TID), with the 2.5 and 5... [URL="http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/0/da"][IMG]http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/1/da"][IMG]http://feedads.g.doubleclick.net/~a/JHfyVHI5y2yMZzqJ9tibtBy61ss/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/wt80nDgy1rc[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/wt80nDgy1rc/3NT7]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top